Upgrade to SI Premium - Free Trial

Nyxoah (NYXH)

0.90 -0.04 (4.26%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 6-K Nyxoah SA For: Oct 20 October 20, 2026 4:15 PM - SEC Filing Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026 October 19, 2026 8:00 AM - StreetInsider Nyxoah reports 12-month ACCCESS study data at ISSS meeting October 15, 2026 4:06 PM - StreetInsider Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 October 15, 2026 4:05 PM - StreetInsider Form 6-K Nyxoah SA For: Sep 29 September 29, 2026 4:05 PM - SEC Filing Nyxoah Appoints Liam Kelly as Chief Executive Officer September 28, 2026 4:30 PM - StreetInsider Form 6-K Nyxoah SA For: Sep 22 September 22, 2026 4:05 PM - SEC Filing CVRx names John Landry as its new chief financial officer September 21, 2026 4:07 PM - StreetInsider CVRx Appoints John Landry as Chief Financial Officer September 21, 2026 4:07 PM - Globe NewsWire Nyxoah CFO steps down; interim replacement named September 21, 2026 4:01 PM - StreetInsider Nyxoah Announces Chief Financial Officer Transition September 21, 2026 4:01 PM - StreetInsider Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH) September 15, 2026 9:30 AM - StreetInsider Nyxoah enrolls first patient in U.S. post-approval Genio study September 7, 2026 5:53 PM - StreetInsider Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System September 7, 2026 4:05 PM - StreetInsider Nyxoah SA (NYXH) Reiterated at Overweight by Cantor Fitzgerald on Label Expansion Potential September 4, 2026 7:21 AM - StreetInsider Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients September 2, 2026 4:05 PM - StreetInsider Nyxoah SA (NYXH) PT Lowered to $6 at Cantor Fitzgerald to Reflect Current Trading Levels August 17, 2026 6:04 AM - StreetInsider Form SCHEDULE 13G/A Nyxoah SA Filed by: CVI Investments, Inc. August 14, 2026 2:45 PM - SEC Filing Nyxoah SA (NYXH) PT Lowered to $4 at Oppenheimer August 6, 2026 8:37 AM - StreetInsider Nyxoah SA (NYXH) PT Lowered to $6 at Piper Sandler August 6, 2026 7:13 AM - StreetInsider Nyxoah S.A. (NYXH) Misses Q2 EPS by 13c August 6, 2026 1:53 AM - StreetInsider Form 6-K Nyxoah SA For: Jun 30 August 5, 2026 4:17 PM - SEC Filing Full Article List